Global Ambulatory Cardiac Monitoring Devices Market

Ambulatory Cardiac Monitoring Devices Comprehensive Study by Type (ECG device, Holter Monitor, Event monitor, Others), End use (Hospitals, Ambulatory Surgical Centre, Diagnostic Centre, Homecare Settings, Emergency Medical service) Players and Region - Global Market Outlook to 2028

Ambulatory Cardiac Monitoring Devices Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Ambulatory Cardiac Monitoring Devices
Ambulatory monitors are devices that are used to record the electrical activity of the human heart. Ambulatory monitors are used to detecting heart rhythm problems for longer periods of time. These monitor devices help to detect the heart with increased detection time and with more precise results as compared to traditional heart monitors. Ambulatory cardiac monitoring devices are used to assist doctors with irregular cardiac arrhythmias which occur only sporadically and unpredictably. Geographically, North America is leading in terms of revenue part from the region which can be attributed to an increase in government and private funding and a large volume of tests for cardiac diseases is performed especially in this region. Ambulatory Cardiac Monitoring Devices are used to monitor patients with syncope or for infrequent rhythm abnormalities and for long-term monitoring of atrial fibrillation post-ablation. Hence this is the key factor that is triggering the market over the forecast period

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The market is expected to grow market in the medical industry. It has rising high blood pressure, obesity, diabetes and more adoption of the monitoring devices are driving the demand for the market. Several companies are operating in the market to provide customers with better offers with various features & unique offerings. The market is a highly fragmented market with the presence of several market players and local players. Which is triggering the market growth over the forecast period Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Medtronic (Ireland), Boston Scientific (Unites States),, Abbott Laboratories (Unites States),, GE Healthcare (United States),, BIOTRONIK (Germany),, Koninklijke Philips (Netherlands), Asahi Kasei Corporation (Japan), Micro port scientific corporation (United States), NUUBO Smart Solutions Technologies, SL(Spain), Koninklijke Philips N.V (Netherlands), Welch Allyn – A Hill-Rom Inc.(United States), Spacelabs Healthcare, Inc (United States), Nihon Kohden Corporation (Japan), Fukuda Denshi Co, Ltd( Japan), Biotelemetry, Inc (United States), AliveCor, Inc (Unites States), Biotronik, Inc (Germany), Medronic, Plc (Ireland) and St. Jude Medical, LLC (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Ambulatory Cardiac Monitoring Devices market by and Region.



On the basis of geography, the market of Ambulatory Cardiac Monitoring Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Type, the sub-segment i.e. ECG device will boost the Ambulatory Cardiac Monitoring Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End use, the sub-segment i.e. Hospitals will boost the Ambulatory Cardiac Monitoring Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
The wireless ECG monitors can be used for the continuous monitoring of patients suffering from CVD and for the detection of problems when they are usually easier to treat while avoiding life-threatening and expensive emergency admissions.

Market Growth Drivers:
It helps to record patient heart rhythm and blood flow regulation in the human body

Challenges:
large amount skilled labour is required

Restraints:
The sampling period is usually for a short period of time which to allow the capture of infrequent arrhythmia.

Opportunities:
Ambulatory monitors are devices is used to record the electrical activity in the human heart.

Market Leaders and their expansionary development strategies
On 21 January 2021 Boston Scientific acquires cardiac sensor maker preventive solutions. Preventive Solutions is a remote patient monitoring device and it has acquired by medical technology firm Boston Scientific for USD 925 million, with as much as USD300 million
On 8th October 2020, Medtronic launches world-first pacemaker which Can Communicate directly with Patients via smartphones and tablets as well as another device


Key Target Audience
OEM (Original Equipment Manufacturer), Equipment Supplier, Regulatory Authorities, New Entrants/Investors, Strategic Business Planners, Governments and End-Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • ECG device
  • Holter Monitor
  • Event monitor
  • Others

By End use
  • Hospitals
  • Ambulatory Surgical Centre
  • Diagnostic Centre
  • Homecare Settings
  • Emergency Medical service

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. It helps to record patient heart rhythm and blood flow regulation in the human body
    • 3.3. Market Challenges
      • 3.3.1. Large amount skilled labour is required
    • 3.4. Market Trends
      • 3.4.1. The wireless ECG monitors can be used for the continuous monitoring of patients suffering from CVD and for the detection of problems when they are usually easier to treat while avoiding life-threatening and expensive emergency admissions.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Ambulatory Cardiac Monitoring Devices, by Type, End use and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Ambulatory Cardiac Monitoring Devices (Value)
      • 5.2.1. Global Ambulatory Cardiac Monitoring Devices by: Type (Value)
        • 5.2.1.1. ECG device
        • 5.2.1.2. Holter Monitor
        • 5.2.1.3. Event monitor
        • 5.2.1.4. Others
      • 5.2.2. Global Ambulatory Cardiac Monitoring Devices by: Type (Value)
        • 5.2.2.1. ECG device
        • 5.2.2.2. Holter Monitor
        • 5.2.2.3. Event monitor
        • 5.2.2.4. Others
      • 5.2.3. Global Ambulatory Cardiac Monitoring Devices by: End use (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Ambulatory Surgical Centre
        • 5.2.3.3. Diagnostic Centre
        • 5.2.3.4. Homecare Settings
        • 5.2.3.5. Emergency Medical service
      • 5.2.4. Global Ambulatory Cardiac Monitoring Devices Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Australia
          • 5.2.4.2.6. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Ambulatory Cardiac Monitoring Devices (Price)
  • 6. Ambulatory Cardiac Monitoring Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Medtronic (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boston Scientific (Unites States),
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott Laboratories (Unites States),
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GE Healthcare (United States),
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BIOTRONIK (Germany),
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Koninklijke Philips (Netherlands)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Asahi Kasei Corporation (Japan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Micro port scientific corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. NUUBO Smart Solutions Technologies, SL(Spain)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Koninklijke Philips N.V (Netherlands)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Welch Allyn – A Hill-Rom Inc.(United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Spacelabs Healthcare, Inc (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Nihon Kohden Corporation (Japan)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Fukuda Denshi Co, Ltd( Japan)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Biotelemetry, Inc (United States)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. AliveCor, Inc (Unites States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
      • 6.4.17. Biotronik, Inc (Germany)
        • 6.4.17.1. Business Overview
        • 6.4.17.2. Products/Services Offerings
        • 6.4.17.3. Financial Analysis
        • 6.4.17.4. SWOT Analysis
      • 6.4.18. Medronic, Plc (Ireland)
        • 6.4.18.1. Business Overview
        • 6.4.18.2. Products/Services Offerings
        • 6.4.18.3. Financial Analysis
        • 6.4.18.4. SWOT Analysis
      • 6.4.19. St. Jude Medical, LLC (United States)
        • 6.4.19.1. Business Overview
        • 6.4.19.2. Products/Services Offerings
        • 6.4.19.3. Financial Analysis
        • 6.4.19.4. SWOT Analysis
  • 7. Global Ambulatory Cardiac Monitoring Devices Sale, by Type, End use and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Ambulatory Cardiac Monitoring Devices (Value)
      • 7.2.1. Global Ambulatory Cardiac Monitoring Devices by: Type (Value)
        • 7.2.1.1. ECG device
        • 7.2.1.2. Holter Monitor
        • 7.2.1.3. Event monitor
        • 7.2.1.4. Others
      • 7.2.2. Global Ambulatory Cardiac Monitoring Devices by: Type (Value)
        • 7.2.2.1. ECG device
        • 7.2.2.2. Holter Monitor
        • 7.2.2.3. Event monitor
        • 7.2.2.4. Others
      • 7.2.3. Global Ambulatory Cardiac Monitoring Devices by: End use (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Ambulatory Surgical Centre
        • 7.2.3.3. Diagnostic Centre
        • 7.2.3.4. Homecare Settings
        • 7.2.3.5. Emergency Medical service
      • 7.2.4. Global Ambulatory Cardiac Monitoring Devices Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Australia
          • 7.2.4.2.6. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Ambulatory Cardiac Monitoring Devices (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Ambulatory Cardiac Monitoring Devices: by Type(USD Million)
  • Table 2. Ambulatory Cardiac Monitoring Devices ECG device , by Region USD Million (2017-2022)
  • Table 3. Ambulatory Cardiac Monitoring Devices Holter Monitor , by Region USD Million (2017-2022)
  • Table 4. Ambulatory Cardiac Monitoring Devices Event monitor , by Region USD Million (2017-2022)
  • Table 5. Ambulatory Cardiac Monitoring Devices Others , by Region USD Million (2017-2022)
  • Table 6. Ambulatory Cardiac Monitoring Devices: by Type(USD Million)
  • Table 7. Ambulatory Cardiac Monitoring Devices ECG device , by Region USD Million (2017-2022)
  • Table 8. Ambulatory Cardiac Monitoring Devices Holter Monitor , by Region USD Million (2017-2022)
  • Table 9. Ambulatory Cardiac Monitoring Devices Event monitor , by Region USD Million (2017-2022)
  • Table 10. Ambulatory Cardiac Monitoring Devices Others , by Region USD Million (2017-2022)
  • Table 11. Ambulatory Cardiac Monitoring Devices: by End use(USD Million)
  • Table 12. Ambulatory Cardiac Monitoring Devices Hospitals , by Region USD Million (2017-2022)
  • Table 13. Ambulatory Cardiac Monitoring Devices Ambulatory Surgical Centre , by Region USD Million (2017-2022)
  • Table 14. Ambulatory Cardiac Monitoring Devices Diagnostic Centre , by Region USD Million (2017-2022)
  • Table 15. Ambulatory Cardiac Monitoring Devices Homecare Settings , by Region USD Million (2017-2022)
  • Table 16. Ambulatory Cardiac Monitoring Devices Emergency Medical service , by Region USD Million (2017-2022)
  • Table 17. South America Ambulatory Cardiac Monitoring Devices, by Country USD Million (2017-2022)
  • Table 18. South America Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 19. South America Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 20. Brazil Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 21. Brazil Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 22. Argentina Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 23. Argentina Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 24. Rest of South America Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 25. Rest of South America Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 26. Asia Pacific Ambulatory Cardiac Monitoring Devices, by Country USD Million (2017-2022)
  • Table 27. Asia Pacific Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 28. Asia Pacific Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 29. China Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 30. China Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 31. Japan Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 32. Japan Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 33. India Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 34. India Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 35. South Korea Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 36. South Korea Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 37. Australia Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 38. Australia Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 39. Rest of Asia-Pacific Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 40. Rest of Asia-Pacific Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 41. Europe Ambulatory Cardiac Monitoring Devices, by Country USD Million (2017-2022)
  • Table 42. Europe Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 43. Europe Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 44. Germany Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 45. Germany Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 46. France Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 47. France Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 48. Italy Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 49. Italy Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 50. United Kingdom Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 51. United Kingdom Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 52. Netherlands Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 53. Netherlands Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 54. Rest of Europe Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 55. Rest of Europe Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 56. MEA Ambulatory Cardiac Monitoring Devices, by Country USD Million (2017-2022)
  • Table 57. MEA Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 58. MEA Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 59. Middle East Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 60. Middle East Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 61. Africa Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 62. Africa Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 63. North America Ambulatory Cardiac Monitoring Devices, by Country USD Million (2017-2022)
  • Table 64. North America Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 65. North America Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 66. United States Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 67. United States Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 68. Canada Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 69. Canada Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 70. Mexico Ambulatory Cardiac Monitoring Devices, by Type USD Million (2017-2022)
  • Table 71. Mexico Ambulatory Cardiac Monitoring Devices, by End use USD Million (2017-2022)
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Company Basic Information, Sales Area and Its Competitors
  • Table 83. Company Basic Information, Sales Area and Its Competitors
  • Table 84. Company Basic Information, Sales Area and Its Competitors
  • Table 85. Company Basic Information, Sales Area and Its Competitors
  • Table 86. Company Basic Information, Sales Area and Its Competitors
  • Table 87. Company Basic Information, Sales Area and Its Competitors
  • Table 88. Company Basic Information, Sales Area and Its Competitors
  • Table 89. Company Basic Information, Sales Area and Its Competitors
  • Table 90. Company Basic Information, Sales Area and Its Competitors
  • Table 91. Ambulatory Cardiac Monitoring Devices: by Type(USD Million)
  • Table 92. Ambulatory Cardiac Monitoring Devices ECG device , by Region USD Million (2023-2028)
  • Table 93. Ambulatory Cardiac Monitoring Devices Holter Monitor , by Region USD Million (2023-2028)
  • Table 94. Ambulatory Cardiac Monitoring Devices Event monitor , by Region USD Million (2023-2028)
  • Table 95. Ambulatory Cardiac Monitoring Devices Others , by Region USD Million (2023-2028)
  • Table 96. Ambulatory Cardiac Monitoring Devices: by Type(USD Million)
  • Table 97. Ambulatory Cardiac Monitoring Devices ECG device , by Region USD Million (2023-2028)
  • Table 98. Ambulatory Cardiac Monitoring Devices Holter Monitor , by Region USD Million (2023-2028)
  • Table 99. Ambulatory Cardiac Monitoring Devices Event monitor , by Region USD Million (2023-2028)
  • Table 100. Ambulatory Cardiac Monitoring Devices Others , by Region USD Million (2023-2028)
  • Table 101. Ambulatory Cardiac Monitoring Devices: by End use(USD Million)
  • Table 102. Ambulatory Cardiac Monitoring Devices Hospitals , by Region USD Million (2023-2028)
  • Table 103. Ambulatory Cardiac Monitoring Devices Ambulatory Surgical Centre , by Region USD Million (2023-2028)
  • Table 104. Ambulatory Cardiac Monitoring Devices Diagnostic Centre , by Region USD Million (2023-2028)
  • Table 105. Ambulatory Cardiac Monitoring Devices Homecare Settings , by Region USD Million (2023-2028)
  • Table 106. Ambulatory Cardiac Monitoring Devices Emergency Medical service , by Region USD Million (2023-2028)
  • Table 107. South America Ambulatory Cardiac Monitoring Devices, by Country USD Million (2023-2028)
  • Table 108. South America Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 109. South America Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 110. Brazil Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 111. Brazil Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 112. Argentina Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 113. Argentina Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 114. Rest of South America Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 115. Rest of South America Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 116. Asia Pacific Ambulatory Cardiac Monitoring Devices, by Country USD Million (2023-2028)
  • Table 117. Asia Pacific Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 118. Asia Pacific Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 119. China Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 120. China Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 121. Japan Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 122. Japan Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 123. India Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 124. India Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 125. South Korea Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 126. South Korea Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 127. Australia Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 128. Australia Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 129. Rest of Asia-Pacific Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 130. Rest of Asia-Pacific Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 131. Europe Ambulatory Cardiac Monitoring Devices, by Country USD Million (2023-2028)
  • Table 132. Europe Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 133. Europe Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 134. Germany Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 135. Germany Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 136. France Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 137. France Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 138. Italy Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 139. Italy Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 140. United Kingdom Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 141. United Kingdom Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 142. Netherlands Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 143. Netherlands Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 144. Rest of Europe Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 145. Rest of Europe Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 146. MEA Ambulatory Cardiac Monitoring Devices, by Country USD Million (2023-2028)
  • Table 147. MEA Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 148. MEA Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 149. Middle East Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 150. Middle East Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 151. Africa Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 152. Africa Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 153. North America Ambulatory Cardiac Monitoring Devices, by Country USD Million (2023-2028)
  • Table 154. North America Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 155. North America Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 156. United States Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 157. United States Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 158. Canada Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 159. Canada Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 160. Mexico Ambulatory Cardiac Monitoring Devices, by Type USD Million (2023-2028)
  • Table 161. Mexico Ambulatory Cardiac Monitoring Devices, by End use USD Million (2023-2028)
  • Table 162. Research Programs/Design for This Report
  • Table 163. Key Data Information from Secondary Sources
  • Table 164. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Ambulatory Cardiac Monitoring Devices: by Type USD Million (2017-2022)
  • Figure 5. Global Ambulatory Cardiac Monitoring Devices: by Type USD Million (2017-2022)
  • Figure 6. Global Ambulatory Cardiac Monitoring Devices: by End use USD Million (2017-2022)
  • Figure 7. South America Ambulatory Cardiac Monitoring Devices Share (%), by Country
  • Figure 8. Asia Pacific Ambulatory Cardiac Monitoring Devices Share (%), by Country
  • Figure 9. Europe Ambulatory Cardiac Monitoring Devices Share (%), by Country
  • Figure 10. MEA Ambulatory Cardiac Monitoring Devices Share (%), by Country
  • Figure 11. North America Ambulatory Cardiac Monitoring Devices Share (%), by Country
  • Figure 12. Global Ambulatory Cardiac Monitoring Devices share by Players 2022 (%)
  • Figure 13. Global Ambulatory Cardiac Monitoring Devices share by Players (Top 3) 2022(%)
  • Figure 14. Global Ambulatory Cardiac Monitoring Devices share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 17. Medtronic (Ireland) Revenue: by Geography 2022
  • Figure 18. Boston Scientific (Unites States), Revenue, Net Income and Gross profit
  • Figure 19. Boston Scientific (Unites States), Revenue: by Geography 2022
  • Figure 20. Abbott Laboratories (Unites States), Revenue, Net Income and Gross profit
  • Figure 21. Abbott Laboratories (Unites States), Revenue: by Geography 2022
  • Figure 22. GE Healthcare (United States), Revenue, Net Income and Gross profit
  • Figure 23. GE Healthcare (United States), Revenue: by Geography 2022
  • Figure 24. BIOTRONIK (Germany), Revenue, Net Income and Gross profit
  • Figure 25. BIOTRONIK (Germany), Revenue: by Geography 2022
  • Figure 26. Koninklijke Philips (Netherlands) Revenue, Net Income and Gross profit
  • Figure 27. Koninklijke Philips (Netherlands) Revenue: by Geography 2022
  • Figure 28. Asahi Kasei Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 29. Asahi Kasei Corporation (Japan) Revenue: by Geography 2022
  • Figure 30. Micro port scientific corporation (United States) Revenue, Net Income and Gross profit
  • Figure 31. Micro port scientific corporation (United States) Revenue: by Geography 2022
  • Figure 32. NUUBO Smart Solutions Technologies, SL(Spain) Revenue, Net Income and Gross profit
  • Figure 33. NUUBO Smart Solutions Technologies, SL(Spain) Revenue: by Geography 2022
  • Figure 34. Koninklijke Philips N.V (Netherlands) Revenue, Net Income and Gross profit
  • Figure 35. Koninklijke Philips N.V (Netherlands) Revenue: by Geography 2022
  • Figure 36. Welch Allyn – A Hill-Rom Inc.(United States) Revenue, Net Income and Gross profit
  • Figure 37. Welch Allyn – A Hill-Rom Inc.(United States) Revenue: by Geography 2022
  • Figure 38. Spacelabs Healthcare, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 39. Spacelabs Healthcare, Inc (United States) Revenue: by Geography 2022
  • Figure 40. Nihon Kohden Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 41. Nihon Kohden Corporation (Japan) Revenue: by Geography 2022
  • Figure 42. Fukuda Denshi Co, Ltd( Japan) Revenue, Net Income and Gross profit
  • Figure 43. Fukuda Denshi Co, Ltd( Japan) Revenue: by Geography 2022
  • Figure 44. Biotelemetry, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 45. Biotelemetry, Inc (United States) Revenue: by Geography 2022
  • Figure 46. AliveCor, Inc (Unites States) Revenue, Net Income and Gross profit
  • Figure 47. AliveCor, Inc (Unites States) Revenue: by Geography 2022
  • Figure 48. Biotronik, Inc (Germany) Revenue, Net Income and Gross profit
  • Figure 49. Biotronik, Inc (Germany) Revenue: by Geography 2022
  • Figure 50. Medronic, Plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 51. Medronic, Plc (Ireland) Revenue: by Geography 2022
  • Figure 52. St. Jude Medical, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 53. St. Jude Medical, LLC (United States) Revenue: by Geography 2022
  • Figure 54. Global Ambulatory Cardiac Monitoring Devices: by Type USD Million (2023-2028)
  • Figure 55. Global Ambulatory Cardiac Monitoring Devices: by Type USD Million (2023-2028)
  • Figure 56. Global Ambulatory Cardiac Monitoring Devices: by End use USD Million (2023-2028)
  • Figure 57. South America Ambulatory Cardiac Monitoring Devices Share (%), by Country
  • Figure 58. Asia Pacific Ambulatory Cardiac Monitoring Devices Share (%), by Country
  • Figure 59. Europe Ambulatory Cardiac Monitoring Devices Share (%), by Country
  • Figure 60. MEA Ambulatory Cardiac Monitoring Devices Share (%), by Country
  • Figure 61. North America Ambulatory Cardiac Monitoring Devices Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Medtronic (Ireland)
  • Boston Scientific (Unites States),
  • Abbott Laboratories (Unites States),
  • GE Healthcare (United States),
  • BIOTRONIK (Germany),
  • Koninklijke Philips (Netherlands)
  • Asahi Kasei Corporation (Japan)
  • Micro port scientific corporation (United States)
  • NUUBO Smart Solutions Technologies, SL(Spain)
  • Koninklijke Philips N.V (Netherlands)
  • Welch Allyn – A Hill-Rom Inc.(United States)
  • Spacelabs Healthcare, Inc (United States)
  • Nihon Kohden Corporation (Japan)
  • Fukuda Denshi Co, Ltd( Japan)
  • Biotelemetry, Inc (United States)
  • AliveCor, Inc (Unites States)
  • Biotronik, Inc (Germany)
  • Medronic, Plc (Ireland)
  • St. Jude Medical, LLC (United States)
Select User Access Type

Key Highlights of Report


Apr 2023 160 Pages 51 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Ambulatory Cardiac Monitoring Devices Market Quantitative research analysis
Global Ambulatory Cardiac Monitoring Devices Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Medtronic (Ireland), Boston Scientific (Unites States),, Abbott Laboratories (Unites States),, GE Healthcare (United States),, BIOTRONIK (Germany),, Koninklijke Philips (Netherlands), Asahi Kasei Corporation (Japan), Micro port scientific corporation (United States), NUUBO Smart Solutions Technologies, SL(Spain), Koninklijke Philips N.V (Netherlands), Welch Allyn – A Hill-Rom Inc.(United States), Spacelabs Healthcare, Inc (United States), Nihon Kohden Corporation (Japan), Fukuda Denshi Co, Ltd( Japan), Biotelemetry, Inc (United States), AliveCor, Inc (Unites States), Biotronik, Inc (Germany), Medronic, Plc (Ireland) and St. Jude Medical, LLC (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"The wireless ECG monitors can be used for the continuous monitoring of patients suffering from CVD and for the detection of problems when they are usually easier to treat while avoiding life-threatening and expensive emergency admissions." is seen as one of major influencing trends for Ambulatory Cardiac Monitoring Devices Market during projected period 2022-2028.
The Ambulatory Cardiac Monitoring Devices market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Ambulatory Cardiac Monitoring Devices Market Report?

Have a Query? Click Here

Other Related Reports

Cardiovascular Proximal Anastomosis Devices Comprehensive Study by Application (Hospitals, Surgery Centers, Clinics, Others), Automation (Automatic, Manual) Players and Region - Global Market Outlook...
$ 3500
Specialty PACS Comprehensive Study by Type (Radiology, Cardiology, Pathology, Oncology, Others), Deployment Mode (Cloud-Based, On-Premises), Components (Imaging Modalities, Communication Networks, PA...
$ 3650
Minimally Invasive Bariatric Surgery Equipments Comprehensive Study by Type (Assisting Devices, Implantable Devices), Application (Bariatric Surgical Centers, Hospitals, Plastic Surgery, Other) Playe...
$ 3500
Branched Stent Grafts Comprehensive Study by Application (Thoracic Aortic Aneurysm, Aortic Dissection), End-User (Hospitals, Clinics, Ambulatory Surgical Centres) Players and Region - Global Market O...
$ 3500
Apolipoprotein Testing Comprehensive Study by Type (Apolipoprotein A, Apolipoprotein B, Apolipoprotein C, Apolipoprotein D, Apolipoprotein E, Apolipoprotein H), Application (Hospital, Clinic, Researc...
$ 3450
Lazy Eye Patchs Comprehensive Study by Type (Normal Size Lazy Eye Patchs, Large Size Lazy Eye Patchs), Design (Embroidery, Decorative stickers, Jewels, Other), Distribution Channel (Online, Offline),...
$ 3800